Temasek Invests in Series B Round for AccuraGen
Posted on 06/03/2016
Sovereign wealth funds continue tactically investing in the pharmaceutical sector. Menlo Park-based AccuraGen, a liquid biopsy technology startup, raised US$ 40 million in a Series B round. AccuraGen is seeking to further develop and commercialize its liquid biopsy invention called Firefly. New investors in the company that participated in the Series B round include Junson […]
